 |
市场调查报告书
商品编码
1629616
生物标记研究服务市场按服务类型、适应症、最终用户和地区划分Biomarker Research Services Market, By Service Type (Biomarker Research Services and Companion Diagnostics Research Services), By Disease Indication, By End User,By Geography . |
||||||
2024 年全球生物标记发现服务市场规模估计为 68.1 亿美元，预计 2031 年将达到 1,911 亿美元，2024 年至 2031 年的复合年增长率为 61%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2023 | 2024 年的市场规模 | 68.1亿美元 |
| 效能资料 | 2019 年至 2023 年 | 预测期 | 2024 年至 2031 年 |
| 预测期间 2024 年至 2031 年复合年增长率： | 61.00％ | 2031 年价值预测 | 1911亿美元 |
由于精准医疗和个人化医疗的日益普及，全球生物标记发现服务市场在过去几年中获得了显着的发展。生物标记透过识别疾病风险和患者对治疗的反应在药物开发中发挥重要作用。生物标记可以帮助简化临床试验并降低与药物开发相关的成本。由于生物标记在疾病早期诊断和标靶治疗开发中越来越受到关注，对生物标记发现的外包服务的需求巨大。各种生物製药公司与研究机构合作，以利用他们的专业知识并最大限度地提高临床研究的效率。这推动了全球生物标誌物发现服务市场的成长。
市场动态：
全球生物标记发现服务市场受到个人化医疗需求的不断增长、精准医疗影响力的不断扩大以及伴同性诊断市场的成长的推动。然而，与生物标记发现和检验相关的高成本以及生物标记发现的技术挑战可能会抑制市场成长。同时，对罕见疾病诊断的日益关注表明该行业参与者俱有巨大的成长潜力。生物标记在罕见疾病药物开发中发挥重要作用。生物标记的使用可以帮助识别适合临床试验的患者并降低成本。基因组学和蛋白质组学等生物标记分析技术的日益普及将在不久的将来带来丰厚的商机。
本研究的主要特点
本报告对全球生物标记发现服务市场进行了详细分析，并提供了预测期（2024-2031）的市场规模和年复合成长率（CAGR%），假设 2023 年为基准年。
它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球生物标誌物发现服务市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
研究涉及的主要企业包括 F. Hoffmann-La Roche Ltd.、雅培实验室、赛默飞世尔科技公司、Bio-Rad Laboratories, Inc.、西门子医疗公司、强生服务公司、Qiagen、Epigenetics AG、通用电气、默克公司、Illumina, Inc.、珀金埃尔默公司、安诺华、通用电气公司和华伦科技公司。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球生物标誌物发现服务市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球生物标记发现服务市场的各种策略矩阵来更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
- 产业趋势
4. 全球生物标记发现服务市场（按服务类型划分），2019 年至 2031 年
- 生物标誌物发现服务
- 伴同性诊断 (CDx) 研究服务
5. 全球生物标记发现服务市场（依适应症划分），2019 年至 2031 年
- 癌症
- 心血管疾病
- 感染疾病
- 神经系统疾病
- 免疫系统疾病
- 其他的
6. 全球生物标记发现服务市场，依最终用户划分，2019 年至 2031 年
- 医院
- 诊断中心
- 专业中心
- 研究组织
7. 全球生物标记发现服务市场（按地区划分），2019 年至 2031 年
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers AG
- Johnson & Johnson Services, Inc.
- Qiagen
- Epigenetics AG
- General Electric
- Merck KGaA
- Illumina, Inc.
- PerkinElmer, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- Novartis AG
第 9 章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The global biomarker research services market is estimated to be valued at USD 6.81 Bn in 2024 and is expected to reach USD 191.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 61% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 6.81 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 61.00% | 2031 Value Projection: | US$ 191.10 Bn |
The global biomarker research services market has been gaining significant traction over the recent past, owing to rising penetration of precision medicine and personalized healthcare. Biomarkers play a crucial role in drug development by identifying the risk of diseases and patients' response to therapies. They help streamline clinical trials and reduce costs associated with drug development. With increasing focus on biomarkers for early diagnosis of diseases and the development of targeted therapies, there has been huge demand for outsourced biomarker research services. Various biopharmaceutical companies are collaborating with research organizations to tap into their expertise and maximize efficiency of clinical research. This has boosted the growth of the global biomarker research services market.
Market Dynamics:
Global biomarker research services market is driven by rising demand for personalized medicine, increasing influence of precision medicine, and growth of companion diagnostics market. However, high costs associated with biomarker discovery and validation, and technical challenges in biomarker discovery are likely to restrain the market growth. Meanwhile, increasing focus on rare disease diagnosis presents high growth potential for players in this industry. Biomarkers play a critical role in drug development for rare diseases. Their use helps identify patients suitable for clinical trials and reduces costs. Growing adoption of biomarker profiling technologies, such as genomics and proteomics, offer lucrative opportunities in the near future.
Key Features of the Study:
This report provides in-depth analysis of the global biomarker research services market, and provides market size (US$ Billion) and the compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biomarker research services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Johnson & Johnson Services, Inc., Qiagen, Epigenetics AG, General Electric, Merck KGaA, Illumina, Inc., PerkinElmer, Inc., Agilent Technologies, Becton, Dickinson and Company, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomarker research services market
Market Segmentation
- By Service Type Insights (Revenue, USD Bn, 2019 - 2031)
- Biomarker Research Services
- Companion Diagnostics (CDx) Research Services
- By Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Cancer
- Cardiovascular Disorders
- Infectious Diseases
- Neurological Disorders
- Immunological Disorders
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Diagnostic Centers
- Specialty Centers
- Research Institutions
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- F.Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers AG
- Johnson & Johnson Services, Inc.
- Qiagen
- Epigenetics AG
- General Electric
- Merck KGaA
- Illumina, Inc.
- PerkinElmer, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biomarker Research Services Market, By Service Type
- Global Biomarker Research Services Market, By Disease Indication
- Global Biomarker Research Services Market, By End User
- Global Biomarker Research Services Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Biomarker Research Services Market, By Service Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Biomarker Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Companion Diagnostics (CDx) Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Biomarker Research Services Market, By Disease Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Biomarker Research Services Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Biomarker Research Services Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Epigenetics AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- General Electric
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- Novartis AG
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
兽医生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按动物类型、产品类型、应用、疾病类型、地区和竞争进行细分，2020-2030 年预测
运动医学血液生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按类型、地区和竞争细分，2020-2030 年预测
2025 年至 2033 年按癌症类型（非小细胞肺癌 (NSCLC)、小细胞肺癌 (SCLC)）、标记类型（EGFR、EML4-ALK、KRAS、BRAF 等）、最终用户（医院、诊断实验室等）和地区分類的肺标记市场报告
肾臟生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按产品类型、技术、最终用户、地区和竞争细分，2020-2030F
全球心臟生物标记诊断产业（2024-2029）
PARP 抑制剂生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按产品、服务、应用、地区和竞争细分，2020-2030 年
中枢神经系统生物标记市场规模、份额、成长分析（按类型、应用、最终用户和地区）- 产业预测，2025 年至 2032 年
生物标誌：各种技术和全球市场
生物标记技术市场规模、份额、成长分析、按测试类型、按产品、按分析技术、按研究领域、按应用、按地区 - 行业预测，2025 年至 2032 年
稀有生物标记检体采集和稳定市场规模、份额、趋势分析报告（按生物标记、最终用途、地区、细分市场预测），2025 年至 2030 年